TNF-α, but not IFN-γ, exerted direct dose-dependent anti-myeloma activity (Fig. 4f) at doses that were in the range of soluble TNF-α levels (50–250 pg/mL) produced in the co-cultures. The gene discussed is IFNG; the disease is plasma cell myeloma.